As of March 2024 Immutep has a market cap of $0.29 Billion. This makes Immutep the world's 6584th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.29 B | 4.61% |
2023 | $0.28 B | 74.94% |
2022 | $0.16 B | -38.63% |
2021 | $0.26 B | 28.54% |
2020 | $0.20 B | 192.13% |
2019 | $70.76 M | 7.29% |
2018 | $65.96 M | 62.83% |
2017 | $40.51 M | -24.9% |
2016 | $53.94 M | -29.42% |
2015 | $76.43 M | 105.96% |
2014 | $37.1 M | -13.17% |
2013 | $42.73 M | -64.92% |
2012 | $0.12 B | -23.44% |
2011 | $0.15 B | |
2009 | $56.67 M |
On Mar 28th, 2024 the market cap of Immutep was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Illumina ILMN | $21.82 B | 7,210.65% | ๐บ๐ธ USA |
FibroGen FGEN | $0.23 B | -22.23% | ๐บ๐ธ USA |
HTG Molecular Diagnostics
HTGM | $1.06 M | -99.64% | ๐บ๐ธ USA |